ArticleJournal of translational medicine2020

C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway.

Liping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.